Table 2.
Most recent preceding colonoscopy findings | First surveillance findings | Guideline-recommended interval for second surveillance (y) | N | Adherent with guidelines N (%) |
Recommendations earlier than guidelines N (%) |
Recommendations later than guidelines N (%) |
Recommendations not available N (%) |
---|---|---|---|---|---|---|---|
Pre-2012 guidelinesa | |||||||
Low-risk adenoma | High-risk adenoma | 3 | 5 | 5 (100) | NA | NA | NA |
Low-risk adenoma | 5–10 implied | 15 | 10 (67) | 4 (27) | 0 | 1 (7) | |
No adenoma | 5–10 implied | 23 | 19 (83) | 2 (9) | 0 | 2 (9) | |
High-risk adenoma | High-risk adenoma | 3 | 22 | 16 (73) | 6 (27) | 0 | 0 |
Low-risk adenoma | 5 | 23 | 11 (48) | 10 (43) | 1 (4) | 1 (4) | |
No adenoma | 5 | 21 | 12 (57) | 6 (29) | 0 | 3 (14) | |
No adenoma | High-risk adenoma | 3 | 33 | 23 (70) | 8 (24) | 1 (3) | 1 (3) |
Low-risk adenoma | 5–10 implied | 57 | 42 (74) | 14 (25) | 0 | 1 (2) | |
Stringent Scenario: No adenoma, assuming no prior advanced adenoma or advanced sessile serrated lesion ever |
5–10 implied | 62 | 56 (90) | 6 (10) | 0 | 0 | |
Liberal Scenario: No adenoma, assuming ≥1 prior advanced adenoma or advanced sessile serrated lesion ever |
5 implied | 62 | 55 (89) | 6 (10) | 1 (2) | 0 | |
Post-2012 guidelines | |||||||
Low-risk adenoma | High-risk adenoma | 3 | 5 | 2 (40) | 1 (20) | 0 | 2 (40) |
Low-risk adenoma | 5 | 19 | 15 (79) | 3 (16) | 0 | 1 (5) | |
No adenoma | 10 | 26 | 0 | 23 (88) | 0 | 3 (12) | |
High-risk adenoma | High-risk adenoma | 3 | 22 | 16 (73) | 6 (27) | 0 | 0 |
Low-risk adenoma | 5 | 31 | 20 (65) | 10 (32) | 0 | 1 (3) | |
No adenoma | 5 | 25 | 16 (64) | 7 (28) | 1 (4) | 1 (4) | |
No adenoma | High-risk adenoma | 3 | 35 | 22 (63) | 12 (34) | 1 (3) | 0 |
Low-risk adenoma | 5–10 implied | 47 | 36 (77) | 9 (19) | 0 | 2 (4) | |
Stringent Scenario: No adenoma, assuming no prior advanced adenoma or advanced sessile serrated lesion ever |
10 | 56 | 12 (21) | 42 (75) | 0 | 2 (4) | |
Liberal Scenario: No adenoma, assuming ≥1 prior advanced adenoma or advanced sessile serrated lesion ever | 5 implied | 56 | 37 (66) | 5 (9) | 12 (21) | 2 (4) | |
Delayed post-2012 guidelines | |||||||
Low-risk adenoma | High-risk adenoma | 3 | 3 | 3 (100) | NA | NA | NA |
Low-risk adenoma | 5 | 3 | 1 (33) | 1 (33) | 1 (33) | 0 | |
No adenoma | 10 | 3 | 0 | 3 (100) | NA | NA | |
High-risk adenoma | High-risk adenoma | 3 | 17 | 12 (71) | 4 (24) | 0 | 1 (6) |
Low-risk adenoma | 5 | 19 | 12 (63) | 5 (26) | 0 | 2 (11) | |
No adenoma | 5 | 13 | 10 (77) | 2 (15) | 0 | 1 (8) | |
No adenoma | High-risk adenoma | 3 | 28 | 22 (79) | 3 (11) | 3 (11) | 0 |
Low-risk adenoma | 5–10 implied | 42 | 33 (79) | 6 (14) | 0 | 3 (7) | |
Stringent Scenario: No adenoma, assuming no prior advanced adenoma or advanced sessile serrated lesion ever |
10 | 54s | 11 (20) | 40 (74) | 0 | 3 (6) | |
Liberal Scenario: No adenoma, assuming ≥1 prior advanced adenoma or advanced sessile serrated lesion ever |
5 implied | 54 | 37 (69) | 3 (6) | 12 (22) | 2 (4) |
For colonoscopies performed prior to September 2012, provider surveillance recommendations were compared to the 2006 USMSTF guidelines.